Skip to main content


Figure 6 | BMC Plant Biology

Figure 6

From: Grape berry ripening delay induced by a pre-véraison NAA treatment is paralleled by a shift in the expression pattern of auxin- and ethylene-related genes

Figure 6

Hypothetical model summarizing the interactions occurring between the hormones mainly involved in the regulation of ripening inception and progression. A. Brassinosteroids and ethylene may trigger the first molecular events associated with ripening inception, with the latter hormone involved in the developmental shift preceding véraison. Ethylene would also negatively regulate auxin action by repressing its biosynthesis and trigger ABA-related genes in order to enable the progression of ripening-associated biochemical changes. A direct positive effect of ethylene on ripening may also be postulated based upon available data. Conventional symbols are used to describe positive and negative interactions. The thickness of the lines indicates the preferential ways of interactions determining ripening inception and progression, whereas dotted lines indicate possible feedback interactions. Interactions occurring between auxin and ABA are complex and still under investigation. B. Hypothetical model explaining auxin-related events occurring upon the NAA treatment (+NAA). This model was assembled based upon the expression of auxin-related genes. The yellow-shaded area indicates a likely range of auxin concentration compatible with its biological activity. Three main responsive phases were identified according to this model: phase I (53-60 DAFB), during which the berry displays a primary homeostatic response most likely due to an unspecific pharmacological reaction; phase II (60-70 DAFB), during which a biologically active concentration of auxin is recovered and a secondary homeostatic response is triggered, and phase III (70-148 DAFB), in which a normal ripening progression is observed.

Back to article page